Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Kramer

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|April 12, 1996
Surveillance for waterborne-disease outbreaks--United States, 1993-1994M H Kramer, B L Herwaldt, G F Craun, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 2003
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndromeD Werber, A Fruth, U Buchholz, et al.
Annals of Hematology|May 1, 1991
A 33-year-old man with an unclassifiable acute lymphoblastic leukemiaM H Kramer, J C Kluin-Nelemans, G C Beverstock, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 2004
[Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice]M van Agthoven, S Wittebol, L M Budel, et al.
Lancet (London, England)|February 25, 1995
Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatmentM H Kramer, P M Kluin, E R Wijburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 1998
First reported outbreak in the United States of cryptosporidiosis associated with a recreational lakeM H Kramer, F E Sorhage, S T Goldstein, et al.
Heredity|February 11, 2010
Variation explained in mixed-model association mappingG Sun, C Zhu, M H Kramer, et al.
Leukemia|June 1, 1991
De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosisM H Kramer, S Raghoebier, G C Beverstock, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 28, 2013
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluationD A Eekman, M M ter Wee, V M H Coupé, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2003
[Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ]M T Groot, G J Ossenkoppele, M H Kramer, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|April 12, 1996
Surveillance for waterborne-disease outbreaks--United States, 1993-1994M H Kramer, B L Herwaldt, G F Craun, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 14, 2003
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndromeD Werber, A Fruth, U Buchholz, et al.
Annals of Hematology|May 1, 1991
A 33-year-old man with an unclassifiable acute lymphoblastic leukemiaM H Kramer, J C Kluin-Nelemans, G C Beverstock, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 2004
[Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice]M van Agthoven, S Wittebol, L M Budel, et al.
Lancet (London, England)|February 25, 1995
Differentiation of follicular lymphoma cells after autologous bone marrow transplantation and haematopoietic growth factor treatmentM H Kramer, P M Kluin, E R Wijburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 1998
First reported outbreak in the United States of cryptosporidiosis associated with a recreational lakeM H Kramer, F E Sorhage, S T Goldstein, et al.
Heredity|February 11, 2010
Variation explained in mixed-model association mappingG Sun, C Zhu, M H Kramer, et al.
Leukemia|June 1, 1991
De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosisM H Kramer, S Raghoebier, G C Beverstock, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 28, 2013
Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluationD A Eekman, M M ter Wee, V M H Coupé, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2003
[Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ]M T Groot, G J Ossenkoppele, M H Kramer, et al.
Pageof 5